搜索临床试验以:Resectable
总计1300个结果
-
maryam ekramzadehShiraz University of Medical Sciences完全的
-
Precision Therapeutics未知
-
European Organisation for Research and Treatment...未知
-
M.D. Anderson Cancer CenterNovartis完全的
-
National Center for Tumor Diseases, HeidelbergPfizer; Roche Pharma AG终止
-
Kyoto University未知
-
Australasian Sarcoma Study GroupPfizer; Peter MacCallum Cancer Centre, Australia未知
-
University Hospital HeidelbergGerman Cancer Research Center未知
-
INSYS Therapeutics Inc完全的
-
INSYS Therapeutics Inc完全的
-
Providence Health & ServicesSanofi; Providence Cancer Center, Earle A. Chiles Research Institute终止
-
Sun Yat-sen UniversityGuangdong Provincial People's Hospital; Second Military Medical University未知
-
Eli Lilly and Company完全的
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)完全的
-
University of UlmPfizer, Berlin Germany; Medac, Hamburg, Germany; Study Group Oncology of Gastrointestinal Tumors...完全的
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)未知
-
Benaroya Research InstituteSanofi完全的
-
Zhejiang Cancer Hospital未知
-
University of UlmMedac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)完全的
-
University of SalzburgBiolitec Pharma Ltd.未知
-
Guangdong Provincial People's Hospital未知
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en Technologie; Research Foundation Flanders完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
Peking University People's HospitalPeking University; Sanofi未知
-
Peking UniversityFudan University; Capital Medical University未知
-
Maisonneuve-Rosemont HospitalHippocrate Research & Development未知
-
Chinese University of Hong Kong未知